Cargando…
Rapid, repeated, low-dose challenges with SIVmac239 infect animals in a condensed challenge window
BACKGROUND: Simian immunodeficiency virus (SIV) infection of nonhuman primates is the predominant model for preclinical evaluation of human immunodeficiency virus (HIV) vaccines. These studies frequently utilize high-doses of SIV that ensure infection after a single challenge but do not recapitulate...
Autores principales: | Greene, Justin M, Weiler, Andrea M, Reynolds, Matthew R, Cain, Brian T, Pham, Ngoc H, Ericsen, Adam J, Peterson, Eric J, Crosno, Kristin, Brunner, Kevin, Friedrich, Thomas C, O’Connor, David H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149191/ https://www.ncbi.nlm.nih.gov/pubmed/25125288 http://dx.doi.org/10.1186/s12977-014-0066-z |
Ejemplares similares
-
T cell response specificity and magnitude against SIVmac239 are not concordant in major histocompatibility complex-matched animals
por: Cain, Brian T, et al.
Publicado: (2013) -
P03-08. Protection against SIVmac239 challenge in a rhesus macaque model conferred by a doxycycline dependent attenuated SIVmac239
por: Page, M, et al.
Publicado: (2009) -
Evolution of SIVmac239 following serial passaging in humanized mice
por: Curlin, James Z., et al.
Publicado: (2022) -
A new strategy for repeated application of adenovirus based vectors: proof-of-concept in rhesus macaques challenged with SIVmac239
por: Sun, C, et al.
Publicado: (2012) -
Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
por: Pedreño-Lopez, Nuria, et al.
Publicado: (2021)